Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 51601
Gene Symbol: LIPT1
LIPT1
0.020 Biomarker disease BEFREE LIPT1 deficiency spares GCS deficiency and has been associated with a biochemical signature of combined 2-oxoacid dehydrogenase deficiency leading to early death or Leigh-like encephalopathy. 28757203 2017
Entrez Id: 51601
Gene Symbol: LIPT1
LIPT1
0.020 Biomarker disease BEFREE LIPT1 deficiency spares the GCS, and resulted in a combined 2-oxoacid dehydrogenase deficiency and early death in one patient and in a less severely affected individual with a Leigh-like phenotype. 24777537 2014
Entrez Id: 8630
Gene Symbol: HSD17B6
HSD17B6
0.010 Biomarker disease BEFREE Eleven were caused by 3β-hydroxy-Δ-C27-steroid oxidoreductase dehydrogenase deficiency, 3 from Δ-3-oxosteroid 5β-reductase deficiency, and 1 had Zellweger spectrum disorder. 28902093 2017
Entrez Id: 7296
Gene Symbol: TXNRD1
TXNRD1
0.010 Biomarker disease BEFREE Eleven were caused by 3β-hydroxy-Δ-C27-steroid oxidoreductase dehydrogenase deficiency, 3 from Δ-3-oxosteroid 5β-reductase deficiency, and 1 had Zellweger spectrum disorder. 28902093 2017
Entrez Id: 5156
Gene Symbol: PDGFRA
PDGFRA
0.010 Biomarker disease BEFREE Kaplan-Meier curves and log-rank tests were used to compare the survival of patients with succinate dehydrogenase subunit A-mutant gastrointestinal stromal tumors with that of KIT/PDGFRA wild-type patients without succinate dehydrogenase deficiency and patients with KIT/PDGFRA-mutant gastrointestinal stromal tumors. 25188872 2015
Entrez Id: 3815
Gene Symbol: KIT
KIT
0.010 GeneticVariation disease BEFREE Kaplan-Meier curves and log-rank tests were used to compare the survival of patients with succinate dehydrogenase subunit A-mutant gastrointestinal stromal tumors with that of KIT/PDGFRA wild-type patients without succinate dehydrogenase deficiency and patients with KIT/PDGFRA-mutant gastrointestinal stromal tumors. 25188872 2015
Entrez Id: 8567
Gene Symbol: MADD
MADD
0.010 Biomarker disease BEFREE This review is focused on recent advances about GSDII and its treatment, and the most recent notions about the management and treatment of other metabolic myopathies will be briefly reviewed, including glycogenosis type V (McArdle disease), glycogenosis type III (debrancher enzyme deficiency or Cori disease), CPT-II deficiency, and ETF-dehydrogenase deficiency (also known as riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency or RR-MADD). 24997454 2015
Entrez Id: 2538
Gene Symbol: G6PC
G6PC
0.010 GeneticVariation disease BEFREE Severe hemolysis and methemoglobinemia following fava beans ingestion in glucose-6-phosphatase dehydrogenase deficiency: case report and literature review. 19263080 2009
Entrez Id: 4306
Gene Symbol: NR3C2
NR3C2
0.010 Biomarker disease BEFREE Similar problems occur when the normal ligand specificity of the aldosterone receptor is lost, as in the syndrome of apparent mineralocorticoid excess due to 11 beta-hydroxysteroid dehydrogenase deficiency. 9300202 1997